Autonomix Medical, Inc. reported on August 25, 2025, that it has increased the total amount of common stock it can sell under an existing sales agreement by $1.4 million, bringing the total to $2.1 million. This allows the company to raise funds through the sale of shares registered under its effective shelf registration statement.